EMMI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.025
EU - Europa 6.520
AS - Asia 1.717
AF - Africa 9
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 17.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.997
PL - Polonia 1.892
IT - Italia 1.262
IE - Irlanda 1.196
SE - Svezia 774
RU - Federazione Russa 672
HK - Hong Kong 571
CN - Cina 519
SG - Singapore 246
JO - Giordania 203
CH - Svizzera 180
GB - Regno Unito 127
DE - Germania 124
VN - Vietnam 68
FI - Finlandia 63
ES - Italia 61
AT - Austria 55
TR - Turchia 35
UA - Ucraina 32
FR - Francia 31
CA - Canada 27
IN - India 23
BE - Belgio 17
SA - Arabia Saudita 14
KR - Corea 12
DK - Danimarca 11
NL - Olanda 9
IL - Israele 7
IR - Iran 7
CZ - Repubblica Ceca 6
GR - Grecia 5
PE - Perù 5
BR - Brasile 3
JP - Giappone 3
PS - Palestinian Territory 3
SC - Seychelles 3
EU - Europa 2
ID - Indonesia 2
MA - Marocco 2
MU - Mauritius 2
MY - Malesia 2
NG - Nigeria 2
AU - Australia 1
IQ - Iraq 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
TW - Taiwan 1
Totale 17.282
Salva come PNG Salva come JPEG
Città #
Warsaw 1.889
Fairfield 1.509
Dublin 1.194
Chandler 850
Ashburn 792
Woodbridge 647
Seattle 576
Houston 529
Cambridge 509
Wilmington 420
Lawrence 403
Altamura 356
Hong Kong 340
Princeton 280
Florence 259
Moscow 220
Ann Arbor 213
Boston 212
Beijing 180
Bern 175
Singapore 154
Buffalo 152
Shanghai 129
San Diego 116
New York 114
Medford 98
Boardman 93
Kent 63
Dong Ket 56
Vienna 55
Falls Church 53
Norwalk 50
Rome 47
Barcelona 44
Los Angeles 39
Hillsboro 35
London 32
Milan 32
Redwood City 29
Guangzhou 24
Castelliri 23
Toronto 23
Andover 20
Lappeenranta 18
Washington 18
West Jordan 18
Brussels 17
Jacksonville 15
Phoenix 15
Genoa 14
Pune 12
Bologna 11
Copenhagen 11
Kilburn 11
Seoul 11
Bari 10
Dearborn 10
Palermo 10
Arezzo 9
Napoli 9
Paris 9
Redmond 9
Campi Bisenzio 8
Nanjing 8
Laurel 7
Helsinki 6
Jinan 6
Munich 6
New Bedfont 6
Old Bridge 6
Pamplona 6
Perugia 6
Riyadh 6
Rolla 6
Siena 6
Brno 5
Cerignola 5
Chicago 5
Hangzhou 5
Inverurie 5
Khobar 5
Lima 5
Naples 5
Padova 5
Trumbull 5
Wuhan 5
Cagliari 4
Empoli 4
Hounslow 4
Izmir 4
Mumbai 4
Naaldwijk 4
Prescot 4
Saint-Fons 4
Sesto Fiorentino 4
Shenzhen 4
St Petersburg 4
Taiyuan 4
Taizhou 4
Tel Aviv 4
Totale 13.465
Salva come PNG Salva come JPEG
Nome #
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 240
Behçet's syndrome patients exhibit specific microbiome signature. 235
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 230
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 212
SIRT1 activity is decreased in lesional psoriatic skin 209
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 206
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 204
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 196
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 174
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 164
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 151
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 140
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 131
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 131
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 129
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 129
ANCA-associated vasculitis in childhood: Recent advances 126
Thrombosis in vasculitis: from pathogenesis to treatment 125
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 116
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 110
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 109
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report 108
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 105
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 105
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 105
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 104
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 104
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 101
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 100
Intravenous immunoglobulin therapy: a snapshot for the internist. 100
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 99
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 99
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 97
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 96
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 95
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 95
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 95
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 94
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 94
Thrombosis in inflammatory bowel diseases: What's the link? 93
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 92
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 89
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 89
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 88
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy. 87
Pulmonary hemorrhage: not only vasculitis. 87
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. 87
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 87
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 87
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 86
Pathogenesis of Behcet Syndrome 85
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion 82
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 81
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 81
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 80
The "multifaceted" onset of vasculitis neuropathy 80
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 79
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy 78
The risk stratification in atrial fibrillation 77
Sharing data of clinical trials 77
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 77
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 77
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 76
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 76
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 76
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 76
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 75
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study 74
Vascular Behçet's syndrome: an update 73
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 73
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 73
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 72
Infliximab and Cogan's syndrome 71
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies 71
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 71
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 70
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 70
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 70
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 70
An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children 70
Kimura’s disease: case report of an Italian young male and response to oral cyclosporine A in an 8 years follow-up 69
Anakinra for resistant Behçet uveitis: why not? 69
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 69
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 68
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 68
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 68
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 67
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 66
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 66
Microparticles: Bridging the gap between autoimmunity and thrombosis 65
Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial 65
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 64
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 64
Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report 64
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 63
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series 63
Prognostic Value of Degree and Types of Anaemia on Clinical Outcomes for Hospitalised Older Patients 63
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 63
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 62
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 62
Totale 9.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.684 0 146 62 173 321 308 329 333 326 233 237 216
2020/20212.768 155 257 102 463 240 211 223 168 307 326 147 169
2021/20221.959 56 75 231 74 50 130 50 215 125 82 281 590
2022/20235.067 450 1.102 267 219 219 878 682 266 496 63 181 244
2023/20242.515 92 172 343 162 164 353 128 483 79 237 154 148
2024/2025896 600 296 0 0 0 0 0 0 0 0 0 0
Totale 17.757